Open Access

[Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression

  • Authors:
    • Ying Ye
    • Juhua Zhuang
    • Guoyu Wang
    • Saifei He
    • Jing Ni
    • Wei Xia
  • View Affiliations

  • Published online on: May 31, 2022     https://doi.org/10.3892/ol.2022.13357
  • Article Number: 237
  • Copyright : © Ye et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

July-2022
Volume 24 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye Y, Zhuang J, Wang G, He S, Ni J and Xia W: [Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression. Oncol Lett 24: 237, 2022
APA
Ye, Y., Zhuang, J., Wang, G., He, S., Ni, J., & Xia, W. (2022). [Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression. Oncology Letters, 24, 237. https://doi.org/10.3892/ol.2022.13357
MLA
Ye, Y., Zhuang, J., Wang, G., He, S., Ni, J., Xia, W."[Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression". Oncology Letters 24.1 (2022): 237.
Chicago
Ye, Y., Zhuang, J., Wang, G., He, S., Ni, J., Xia, W."[Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression". Oncology Letters 24, no. 1 (2022): 237. https://doi.org/10.3892/ol.2022.13357